Abbreviations: FBDD -fragment-based drug design; SAR -structure-activity relationship; NTMnon-tuberculous mycobacteria; SAM -S-adenosyl methionine; SAH -S-adenosyl homocysteine; LELigand Efficiency; MIC -minimum inhibitory concentration.
Introduction

26
Mycobacteria are a group of diverse organisms that include many important human pathogens. 27
Within this group, Mycobacterium tuberculosis, the causative agent of Tuberculosis, is 28 responsible for over 1.7 million deaths per year (Floyd et al., 2018) . Nevertheless, 29
Mycobacterium abscessus, a rapid growing species of nontuberculous mycobacteria (NTM), 30
has recently emerged as a major threat to individuals with cystic fibrosis (CF) and other chronic 31 inflammatory lung conditions (Bar-On et al., 2015; Sood and Parrish, 2017) , with infection 32 rates increasing around the World (Floto et al., 2016) . M. abscessus is intrinsically resistant to 33 most antibiotics and is consequently associated with extremely high treatment failure rates 34 (Floto et al., 2016) . There is therefore an urgent unmet need to develop new antibiotics. Mutations in trmD result in growth defects associated with increased translational 45 frameshifting leading to defective protein production (Bjork et al, 1989; Urbonavicius, 2001) . 46
TrmD belongs to a distinct class of S-adenosyl-L-methionine (SAM)-dependent 47
resulting in 53 hits within a thermal shift cut-off value of 3 standard deviations from the 151 negative control, consisting of TrmD protein in the absence of any ligand. These hits were then 152 selected for subsequent experiments by X-ray crystallography. Apo crystals of M. abscessus 153
TrmD were soaked with each of the 53 fragments in individual experiments. The resulting 154 crystal structure determinations helped in the characterization of the binding modes of 27 155 fragments ( Figure S3) . 156
All of the 27 fragments, validated by X-ray crystallography, were found to occupy the TrmD 157 SAM site. These fragments can be clustered into three groups based on their mode of binding 
D & S3). These interactions include hydrogen-bond contacts to the side chain of Ser13and 163
to the backbone amides of Ile133, Gly134, Try136 and Leu138. 164
The second cluster consists of 12 further fragments that occupy the entire adenosine region of 165 the TrmD active site, thus extending from adenine towards the ribose-binding pocket of the 166 active site. These fragments, in addition to retaining several adenine moiety contacts, also 167 interact with the wall loop residues, forming hydrogen bonds to the backbone amides of Tyr111 168 and Gly109 and water-mediated hydrogen bonds as shown in the example (Figure 2 D & S3) . 169
Cluster 3 consists of three fragments that extend beyond the TrmD adenosine site, thus 170 reaching the methionine-binding region of the pocket. One of these fragments, fragment 8 171 stretched further into the groove formed between the cover and wall loops of the trefoil knot, 172 thus engaging additional hydrogen bonding contacts with the side chain of Thr84 and the back 173 bone amide of Gly109 in this region (Figure 2 D & S3) . 174 To aid the structure-guided lead discovery, the binding propensities of TrmD protein to ligands 198 were further examined using the hotspot-mapping program developed by Radoux and co-199 workers (Radoux et al., 2016) . Hotspots are areas within the protein that provide relatively 200 large contributions to the overall binding affinity of ligands (Hajduk et al., 2005; Ichihara et al., 201 2014) . This is usually mediated by the displacement of water molecules having restricted 202 freedom owing to their location within a hydrophobic cavity or close to a patchwork of 203 hydrogen bonds and lipophilic amino acid side chains, thus compensating for the loss of entropy 204 on binding. These regions not only satisfy the minimum binding requirement for fragments but 205 also maintain the original fragment binding interactions when elaborated (Radoux et al., 2016) . 206
While the observed fragment hits and the corresponding merged compound AW1 satisfy many 207 of the predicted protein-hotspot interactions, the map at lower contours also suggests "warm 208 (Table 2) . Surprisingly, AW6, in which the nitrile 271 group was removed, was the least active lead compound in the in vitro TrmD assays, with ~15-272 fold worse Kd and ~50-fold higher IC50, but showed similar MICs when compared to the other 273 two compounds. Additionally, the substitution of the pyrrolidine ring of AW5 with an N-274 methyl piperazine motif in AW7 that also showed a slight worsening of activity in vitro againstTrmD, displayed a 2-fold improvement in the MIC compared to AW5 against M. tuberculosis, 276 but such effect wasn't observed in M. abscessus (Table 2) . Two of the lead molecules (AW6 277
and AW7) were then tested against a wider panel of nontuberculous mycobacteria (NTMs) 278 (Table 2) We assessed the cytotoxicity effect of AW6 and AW7 using lactate dehydrogenase (LDH) 289 release assay. At or below 150 µM, neither compound caused cellular toxicity on human 290 macrophages ( Figure S4) . The compounds were then evaluated in M. abscessus-infected 291 human macrophages. Both compounds showed activity in the macrophage infection model, 292
with AW7 performing better than in the in vitro assays. At 25 µM AW6 showed a ~82 % 293 decrease in CFUs while AW7 at the same concentration showed a 95 % reduction in CFUs 294 compared to the no drug control after 48h incubation ( Figure 5C ). However, only AW7 295 demonstrated a bactericidal effect with a -0.8 log change after 48h incubation ( Figure S7) . 296
The best lead molecule (AW7) was further tested against M. leprae maintained intracellularly 297 in murine bone marrow macrophage. Relative inhibition of β-oxidation rates were measured 298 using radiorespirometry assay after 7 days of incubation. The results show that AW7 at 6.2 µM 299 was able to inhibit M. leprae radiorespirometry by ~54 % when compared to the no-drugcontrol and by ~89 % at 25 µM, which is similar to rifampicin inhibition at 2.4 µM (91%) 301 ( Figure 5D ). While axenically-maintained M. leprae showed only a 15% reduction of 302 radiorespirometry at 25 µM and no effect at 6. 
Isolation of cells & lysis:
Cells were harvested by centrifugation at 4°C for 20 min at 5000 g 366 and the pellet was re-suspended in buffer A (25 mM Hepes pH 7.5, 500 mM NaCl, 5% Glycerol, 367 10 mM MgCl2, 1 mM TCEP, 20 mM Imidazole). 0.1 % Triton (Sigma), 10 μg/mL DNaseI, 5 368 mM MgCl2, and 3 protease inhibitor cocktail tablets (New England Biolabs) were added to the 369 cell suspension. The cells were lysed in an Emulsiflex (Glen Creston) and clarified the lysate 370 by centrifugation at 4°C for 40 min at 25,568 g. 371
Immobilized Metal Affinity Chromatography: The clarified lysate was filtered using a 0.45 μm 372 syringe filter and passed through a pre-equilibrated (with buffer A), 10 mL pre-packed nickel-373 sepharose column (HiTrap IMAC FF, GE Healthcare). The column was washed with 5 column 374 volumes of buffer A and the bound protein was eluted as 4x 10ml elutes using buffer B (25 375 mM Hepes pH 7.5, 500 mM NaCl, 5% Glycerol, 1 mM TCEP, 500 mM Imidazole). The protein 376 was analyzed on a 15% SDS-PAGE gel. Dialysis: Elutes from Hi-Trap IMAC column were 377 pooled, added 3C Protease in the ratio of 1: 50 mg (protease: protein) and subjected to dialysis 378 against 2 L of buffer C (25 mM Hepes pH 7.5, 500 mM NaCl, 5 % Glycerol, 1 mM TCEP) 379 overnight at 4°C. 380
Protein, after overnight dialysis and cleavage of N-His tag, was passed through a pre-381 equilibrated (buffer A) 5 mL HiTrap IMAC FF Nickel column (GE Healthcare). 382
Size Exclusion Chromatography: The flow through from the above column was concentrated 383 to 3 mL using a 10 kDa centrifugal concentrator (Sartorius Stedim) and loaded onto a pre-384 equilibrated (with buffer D: 25 mM Hepes pH 7.5, 500 mM NaCl, 5 % Glycerol) 120 ml 385 Superdex200 16/600 column (GE Healthcare). 2 mL fractions were collected and analyzed on 386 a 15% SDS-PAGE gel. Fractions corresponding to pure TrmD protein were pooled and 387 concentrated to 25mg/ml, flash frozen in liquid nitrogen and stored at -80°C. Identity of the 388 purified protein was further confirmed by MALDI fingerprinting. 389
390
Crystallization of apo form of full length M. abscessus TrmD 391
M. abscessus TrmD apo crystals were grown in 48-well sitting drop plates (Swiss CDI) in the 392 following condition: 0.08 mM Sodium cacodylate pH 5.8 to 6.8, 1-2 M Ammonium sulphate. 393 24 mg/mL of the protein in storage buffer (25 mM Hepes pH 7.5, 500 mM NaCl, 5% Glycerol) 394 at drop ratio 1 μL: 1 μL (protein: reservoir respectively) were set up and equilibrated against 395 70 μL reservoir. 396 397
Soaking of TrmD native crystals with fragments and ligands 398
Crystals for this experiment were grown at 19°C in 48-well sitting drop plates (Swiss CDI) in 399 the following condition: 0.08 mM Sodium cacodylate pH 6.5 to 7.0, 1-2 M Ammoniumsulphate, 20 mg/mL of the protein in storage buffer (25 mM Hepes pH 7.5, 500 mM NaCl, 5% 401 Glycerol) at drop ratio 1 μL: 1 μL were set up and equilibrated against 250 μL reservoir. Further, 402 the crystals were picked and allowed to soak in a 4 μL drop containing reservoir solution and 403 10 mM fragments/compound (in DMSO) which was then equilibrated against 700 μL of the 404 corresponding reservoir solution overnight at 19°C in 24-well hanging drop vapour diffusion 405 set up. Hepes pH 7.5, 500 mM NaCl, 5% glycerol) the same buffer was used for preparing the ligand 458 solutions. Composition of buffer components and other constituents like DMSO were kept 459 constant in both protein and ligand solutions. Ligands to buffer titrations were subtracted in all 460
cases and experiments were repeated at least twice. Data were analysed using the Origin 461 software (OriginLab, Northampton, MA, USA). 462
463
Biochemical activity assays 464
Assays for quantifying TrmD methylation reactions were carried out in 20uL reactions 465 consisting of 6.25 μM SAM, 0.1 μM TrmD and 6.25 μM tRNA in the presence of 0-500 μM 466 compounds in serial dilutions using assay buffer containing 50 mM Tris-HCl pH 7.5, 10 mM 467 MgCl2, 24 mM NH4Cl, 5% DMSO and 1 mM DTT in nuclease free water. tRNA sequences 468 were identified from the M. abscessus genome sequence using tRNAscan-SE algorithm, (Lowe 469 and Chan, 2016; Lowe and Eddy, 1997). The substrate tRNA Pro for the assay was purchased 470 commercially from Integrated DNA technologies (USA). The reactions were carried out for 1 471 h at room temperature followed by addition of 20 mM EDTA to stop the reactions. Each of the 472 20 uL samples were diluted ten-fold with the UPLC mobile phase solvent A (0.1%formic acid 473 in water), centrifuged for 10 min at 13,000 g, to remove any precipitates, and the supernatant 474 was aliquoted into 96-well plates. 40uL samples were then injected into Acquity UPLC(Waters) T3 1.8 μM column and eluted using a gradient elution consisting of Mobile Phase A: 476 0.1% Formic acid in water and mobile phase B: 0.1% Formic acid in 100% Methanol for 4 min. 477
The absorbance was monitored using a photodiode array (PDA) detector (Waters) at 478 wavelength range of ƛ: 220-500 nm. All reactions were carried out in triplicate. The blank 479 corrected data were analysed using Microsoft excel and non-linear regression analysis for IC50 480 determination were done using Graph Pad prism version 7.00, GraphPad Software, La Jolla 481 California USA. were processed for radiorespirometry (RR) as described previously (Lahiri et al., 2005) . and then washed to remove extracellular bacteria. AW7 was added at different concentrations 548
(100 μM -6.25 μM) and the cells were incubated for 7 days at 33 o C. Media only and rifampicin 549 at 2.4 μM were used as negative and positive controls. AW7 treated and control cells werelysed with sodium dodecyl sulfate (SDS, 0.1% w/v, Sigma, USA) and the intracellular M. 551 leprae processed for radiorespirometry (Lahiri et al., 2010) . 552
553
Radiorespirometry 554
Metabolism of a suspension of M. leprae was measured by evaluating the oxidation of 555 14 C-palmitic acid to 14 CO2 by radiorespirometry as described previously (Franzblau, 1988) . 556
Levels of captured
14 CO2 is proportional to the rate of 14 C-palmitic acid oxidation and used as 557 an indicator of M. leprae viability. In the present study the 7 th day cumulative counts per 558 minute (CPM) were recorded and percentage inhibition of metabolism determined as compared 559 to no drug control. Statistical significance between treatment groups and no drug control were 560 determined by Student's t-test and P <0.05 is considered as significant. 
